FGFR4 and colorectal carcinoma: Ahmed et al. (2016) investigated CRC cells that can resist radiotherapy via expression of FGFR4 and discovered that inhibiting FGFR4 can weaken the RAD51-mediated double strain break (DSB) repair, hence attenuating the anti-radiation effect.